Premier Biomedical, Inc. (OTCMKTS:BIEI) Short Interest Up 98.0% in May

Premier Biomedical, Inc. (OTCMKTS:BIEI) saw a significant increase in short interest during the month of May. As of May 29th, there was short interest totaling 1,184,526 shares, an increase of 98.0% from the May 14th total of 598,286 shares. Based on an average daily trading volume, of 53,713,429 shares, the short-interest ratio is presently 0.0 days.

Premier Biomedical Stock Performance

Shares of BIEI remained flat at $0.00 during mid-day trading on Tuesday. The stock had a trading volume of 902,660 shares, compared to its average volume of 19,352,389. Premier Biomedical has a 52 week low of $0.00 and a 52 week high of $0.00.

Premier Biomedical Company Profile

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.